With all the research on vaccines, it may be that we’ve seen too much of the same, writes Philip Weiss.
But while the world has been inundated with vaccines that have been proven effective against other strains of the virus, a new research paper from Johns Hopkins University suggests that the vaccines against the coronavirus may be helping others spread the virus.
While the study does not prove that vaccines are the cause of the spread of coronaviruses, the authors of the paper say that their findings suggest that vaccines may be one possible avenue by which to fight the spread.
“This is not a new idea,” says Daniel Schuch, an infectious diseases professor at Johns Hopkins.
“It’s been seen in several other countries.
We’re not saying it’s the only thing.
But I think this is an intriguing avenue of research.”
The paper was published Monday in the journal Science.
Schuch says he and his colleagues, who were not involved in the study, had hoped to find a connection between the spread and the use of coronivirus vaccines.
“The idea is to say, ‘Is this going to stop this from happening, or is this going, ‘Oh, we’ll just make this a little bit easier?'” says Schuch.
“I think the question is, ‘How is this different from a coronaviral vaccine?'”
While coronavirems have been tested in animals, Schuch believes the vaccine that’s being used in humans will also be able to prevent the spread, as well as other factors that can lead to the spread or infection of COVID.
“You have to get to the heart of it,” says Schoch.
“And I think what we’re starting to see is that it is not necessarily that vaccines aren’t effective.
There are things that we have to look at to make sure that we are really addressing these issues that are going to lead to this.”
Schuch says it’s possible that the use in humans of a vaccine that has already been approved in humans could lead to another development.
“If you were to try to do something that is already in use, that you’ve already had in animals and you wanted to do it in humans, that would be an interesting approach,” says Schneider.
“But I think the answer is, we’re still at a point where we’re not there yet.
We haven’t yet seen a vaccine as effective as the one that was already approved in animals that is as effective in humans.”
In the meantime, Schoch says, he and other scientists are taking a wait-and-see approach.
“We want to see what the results are and then we’re going to continue to try and figure out what is the most effective vaccine,” says the Johns Hopkins professor.
“And then we have a chance to go back to the drawing board to see if we can find a way to do that in the future.”
The Associated Press contributed to this report.